CCL2 and Sepsis: Accumulating evidence demonstrates that the inhibition or specific antagonism of MCP-1 results in decreased release of TNF-α, IL-1β and IL-6 by macrophages and confers survival benefits on mice following sepsis [20, 21, 48, 49].